Cimetidine-nicoumalone interaction in man: stereochemical considerations. 1989

T S Gill, and K J Hopkins, and J Bottomley, and S K Gupta, and M Rowland
Department of Pharmacy, University of Manchester.

1. The cimetidine-nicoumalone interaction was studied in five subjects who received a single 10 mg oral dose of racemic nicoumalone alone and 3 days into an oral regimen of cimetidine of 200 mg three times daily and 400 mg at night. 2. The concentrations of R(+)- and S(-)-nicoumalone in plasma were measured using a stereospecific h.p.l.c assay; augmentation of prothrombin time was used as a measure of response. 3. Cimetidine increased the rate (but not extent) of absorption of both R(+)- and S(-)-nicoumalone, and reduced the clearance of R(+)-nicoumalone but not that of the S(-)-enantiomer. 4. Cimetidine increased the anticoagulant response produced by nicoumalone in some but not all subjects, despite a consistent effect on the pharmacokinetics of the oral anti-coagulant. 5. Cimetidine appears to produce its effect by stereoselectively inhibiting the elimination of R(+)-nicoumalone.

UI MeSH Term Description Entries
D008297 Male Males
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074 Acenocoumarol A coumarin that is used as an anticoagulant. Its actions and uses are similar to those of WARFARIN. (From Martindale, The Extra Pharmacopoeia, 30th ed, p233) Acenocoumarin,Nicoumalone,Mini-Sintrom,Sinkumar,Sinthrome,Sintrom,Syncoumar,Syncumar,Synthrom,Mini Sintrom,MiniSintrom
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer

Related Publications

T S Gill, and K J Hopkins, and J Bottomley, and S K Gupta, and M Rowland
December 1983, British journal of clinical pharmacology,
T S Gill, and K J Hopkins, and J Bottomley, and S K Gupta, and M Rowland
January 1986, Clinical pharmacology and therapeutics,
T S Gill, and K J Hopkins, and J Bottomley, and S K Gupta, and M Rowland
April 1980, Annals of internal medicine,
T S Gill, and K J Hopkins, and J Bottomley, and S K Gupta, and M Rowland
August 1979, Lancet (London, England),
T S Gill, and K J Hopkins, and J Bottomley, and S K Gupta, and M Rowland
May 1984, Archives of internal medicine,
T S Gill, and K J Hopkins, and J Bottomley, and S K Gupta, and M Rowland
June 1990, The Journal of pharmacology and experimental therapeutics,
T S Gill, and K J Hopkins, and J Bottomley, and S K Gupta, and M Rowland
October 1986, The British journal of clinical practice,
T S Gill, and K J Hopkins, and J Bottomley, and S K Gupta, and M Rowland
December 1954, The Journal of pharmacy and pharmacology,
T S Gill, and K J Hopkins, and J Bottomley, and S K Gupta, and M Rowland
October 1988, Anesthesiology,
T S Gill, and K J Hopkins, and J Bottomley, and S K Gupta, and M Rowland
January 1979, G.E.N,
Copied contents to your clipboard!